| 000 | 01198 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518091842.0 | ||
| 264 | 0 | _c20210106 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1016/j.annonc.2020.02.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Dongen, M G J | |
| 245 | 0 | 0 |
_aMise en place: toward neoadjuvant chemoimmunotherapy for early triple-negative breast cancer. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c05 2020 |
||
| 300 |
_a556-557 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aKok, M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 31 _gno. 5 _gp. 556-557 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.annonc.2020.02.014 _zAvailable from publisher's website |
| 999 |
_c30741942 _d30741942 |
||